| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |